2023 Drug Pricing Insurance Coverage and Processing 
Pharmacy Times
JUNE 16, 2025
According to Trump, patients could see cost reductions of 30% to 80%, but experts question the feasibility and practicality of implementing such a policy within the complex United States drug pricing and supply system. Kennedy Jr, is permitted to develop a new rule that ties American drug prices to those of other nations.
PharmaTech
AUGUST 1, 2025
All costs and expenses associated with Prize acceptance and use not specified herein as being provided such as reservation fees, taxes, insurance and other expenses incurred by accepting the Prize are the sole responsibility of the Winner. All federal, state, and local laws and regulations apply.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 9, 2025
The first collaboration was announced in March 2023 for neurodegenerative diseases, and the second in December 2023 focused on discovering oligonucleotide therapeutics. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.
Pharmaceutical Technology
JULY 25, 2025
EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? According to GlobalData, the CGT market was estimated to be $5.88bn in 2023 and is projected to reach $80bn by 2029. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.
Putting Patients First Blog
SEPTEMBER 3, 2024
The NHC appreciates CMS’ efforts to gather patient-centered data as part of this ICR and its commitment to making the process more relevant for patients and patient organizations. While we acknowledge these improvements, it is important to note that some aspects of the data collection process may remain challenging.
Pharma in Brief
JULY 19, 2023
CADTH Time-Limited Reimbursement Recommendations Starting in the fall of 2023, CADTH, which conducts health technology assessments ( HTAs ) to inform public insurers, will introduce time-limited reimbursement recommendations for certain drug products. The deadline to provide input is August 18, 2023.
Putting Patients First Blog
JULY 2, 2024
General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). The NHC provides the following comments to CMS to improve on the steps it has already taken to date.
Expert insights. Personalized for you.
Let's personalize your content